Ignite Creation Date:
2024-07-17 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470048
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-17
Brief Title:
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diffuse Cutaneous Systemic Sclerosis |
Keywords:
| Name | View |
|---|---|
| Diffuse Cutaneous Systemic Sclerosis dcSSc | View |
| Diffuse Scleroderma | View |
| Diffuse Systemic Sclerosis | View |
| Scleroderma Diffuse | View |
| Scleroderma Progressive | View |
| Sclerosis Progressive Systemic | View |
| Sudden Onset Scleroderma | View |
| B cell depletion | View |
| Revised Composite Response Index in Systemic Sclerosis 25 rCRISS25 | View |
| modified Rodnan skin score | View |
| forced vital capacity | View |